N A Payne - JoVE Visualize

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Prostaglandins|April 1, 1977

Identification of the major urinary metabolite of thromboxane B2 in the monkeyL J Roberts, B J Sweetman, J L Morgan, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998

Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3AR L Voorman, S M Maio, N A Payne, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 1998

Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3AR L Voorman, S M Maio, M J Hauer, et al.

Circulation Research|November 1, 1983

Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandinsG D Johnston, W R Hiatt, A S Nies, et al.

Science (New York, N.Y.)|September 17, 1976

Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2E F Ellis, O Oelz, L J Roberts, et al.

Bioorganic & Medicinal Chemistry Letters|May 1, 2012

Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarringMark L Boys, Feng Bian, James B Kramer, et al.

Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Prostaglandins|April 1, 1977

Identification of the major urinary metabolite of thromboxane B2 in the monkeyL J Roberts, B J Sweetman, J L Morgan, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998

Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3AR L Voorman, S M Maio, N A Payne, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 1998

Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3AR L Voorman, S M Maio, M J Hauer, et al.

Circulation Research|November 1, 1983

Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandinsG D Johnston, W R Hiatt, A S Nies, et al.

Science (New York, N.Y.)|September 17, 1976

Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2E F Ellis, O Oelz, L J Roberts, et al.

Bioorganic & Medicinal Chemistry Letters|May 1, 2012

Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarringMark L Boys, Feng Bian, James B Kramer, et al.

Pageof 3